DK0635015T3 - Acylaminoindolderivater som 5-Htl agonister - Google Patents

Acylaminoindolderivater som 5-Htl agonister

Info

Publication number
DK0635015T3
DK0635015T3 DK93907096.7T DK93907096T DK0635015T3 DK 0635015 T3 DK0635015 T3 DK 0635015T3 DK 93907096 T DK93907096 T DK 93907096T DK 0635015 T3 DK0635015 T3 DK 0635015T3
Authority
DK
Denmark
Prior art keywords
aryl
alkyl
alkylaryl
hydrogen
pct
Prior art date
Application number
DK93907096.7T
Other languages
English (en)
Inventor
John E Macor
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of DK0635015T3 publication Critical patent/DK0635015T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, ***e
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Materials For Photolithography (AREA)
  • Soft Magnetic Materials (AREA)
  • Supply Devices, Intensifiers, Converters, And Telemotors (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrrole Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
DK93907096.7T 1992-04-10 1993-03-04 Acylaminoindolderivater som 5-Htl agonister DK0635015T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US86638292A 1992-04-10 1992-04-10

Publications (1)

Publication Number Publication Date
DK0635015T3 true DK0635015T3 (da) 1997-03-17

Family

ID=25347493

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93907096.7T DK0635015T3 (da) 1992-04-10 1993-03-04 Acylaminoindolderivater som 5-Htl agonister

Country Status (31)

Country Link
US (1) US5498626A (da)
EP (1) EP0635015B1 (da)
JP (1) JP2544704B2 (da)
KR (1) KR0179074B1 (da)
CN (1) CN1038506C (da)
AT (1) ATE148465T1 (da)
AU (1) AU670270B2 (da)
BR (1) BR9306221A (da)
CA (1) CA2132706C (da)
CZ (1) CZ282653B6 (da)
DE (1) DE69307875T2 (da)
DK (1) DK0635015T3 (da)
EG (1) EG20466A (da)
ES (1) ES2097496T3 (da)
FI (2) FI111256B (da)
GR (1) GR3022767T3 (da)
HR (1) HRP930753B1 (da)
HU (1) HUT64060A (da)
IL (1) IL105309A0 (da)
MX (1) MX9301996A (da)
MY (1) MY115278A (da)
NO (1) NO309860B1 (da)
NZ (1) NZ251047A (da)
PL (1) PL172232B1 (da)
RU (1) RU2110516C1 (da)
SK (1) SK278182B6 (da)
TW (1) TW394769B (da)
UA (1) UA34452C2 (da)
WO (1) WO1993021180A1 (da)
YU (1) YU48916B (da)
ZA (1) ZA932536B (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5545644A (en) * 1990-10-15 1996-08-13 Pfizer Inc. Indole derivatives
US5559129A (en) * 1990-10-15 1996-09-24 Pfizer Inc Indole derivatives
US5559246A (en) * 1990-10-15 1996-09-24 Pfizer Inc. Indole derivatives
US5578612A (en) * 1990-10-15 1996-11-26 Pfizer Inc. Indole derivatives
US5607951A (en) * 1990-10-15 1997-03-04 Pfizer Inc Indole derivatives
PL172405B1 (en) 1992-04-07 1997-09-30 Pfizer Derivatives of indole
US6380233B1 (en) 1992-04-07 2002-04-30 Pfizer Inc Indole derivatives as 5-HT1 agonists
ES2070772B1 (es) * 1993-08-09 1996-02-16 Pfizer Derivados de acilaminoindol
EP0716649B1 (en) * 1993-08-31 1998-09-09 Pfizer Inc. 5-arylindole derivatives
GB9402016D0 (en) * 1994-02-02 1994-03-30 Merck Sharp & Dohme Therapeutic agents
GB9402011D0 (en) * 1994-02-02 1994-03-30 Merck Sharp & Dohme Therapeutic agents
AU3162695A (en) * 1994-08-03 1996-03-04 Asta Medica Aktiengesellschaft Indol, indazol, pyridopyrrol and pyridopyrazol derivatives with anti-asthmatic, anti-allergic, anti-inflammatory and immunomodulating effects
GB9417310D0 (en) * 1994-08-27 1994-10-19 Pfizer Ltd Therapeutic agents
GB9420503D0 (en) * 1994-10-11 1994-11-23 Pfizer Ltd Therapeutic agents
GB9420529D0 (en) 1994-10-12 1994-11-30 Pfizer Ltd Indoles
WO1999053956A1 (fr) * 1998-04-16 1999-10-28 Yamanouchi Pharmaceutical Co., Ltd. Remedes contre l'obesite
US5994352A (en) * 1998-11-13 1999-11-30 Pfizer Inc. 5-arylindole derivatives
US20050032750A1 (en) * 2003-01-22 2005-02-10 Steiner Mitchell S. Treating androgen deficiency in female (ADIF)-associated conditions with SARMS
CA2708043C (en) * 2007-12-07 2012-11-13 Pfizer Inc. Tosylate salt of trans-n-isobutyl-3-fluoro-3- [3-fluoro-4- (pyrrolidin-1-yl-methyl) -phenyl] cyclobut anecarboxamide
JP6440625B2 (ja) 2012-11-14 2018-12-19 ザ・ジョンズ・ホプキンス・ユニバーシティー 精神***病を処置するための方法および組成物
CN103408535B (zh) * 2013-08-13 2016-03-02 张家港威胜生物医药有限公司 一种依来曲普坦中间体-5-溴-3-(n-甲基吡咯啉-2-基甲基)-1h-吲哚合成工艺

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA795239B (en) * 1978-10-12 1980-11-26 Glaxo Group Ltd Heterocyclic compounds
CH652394A5 (fr) * 1980-08-12 1985-11-15 Glaxo Group Ltd Derives indoliques, leur preparation et medicaments les renfermant.
ZA815541B (en) * 1980-08-12 1983-03-30 Glaxo Group Ltd Heterocyclic compounds
GB8600397D0 (en) * 1986-01-08 1986-02-12 Glaxo Group Ltd Chemical compounds
GB8719167D0 (en) * 1987-08-13 1987-09-23 Glaxo Group Ltd Chemical compounds
GB8724912D0 (en) * 1987-10-23 1987-11-25 Wellcome Found Indole derivatives
GB8819024D0 (en) * 1988-08-10 1988-09-14 Glaxo Group Ltd Chemical compounds
IL96891A0 (en) * 1990-01-17 1992-03-29 Merck Sharp & Dohme Indole-substituted five-membered heteroaromatic compounds,their preparation and pharmaceutical compositions containing them
CA2042295A1 (fr) * 1990-05-15 1991-11-16 Jacques Chauveau Derives de mediateurs endogenes, leurs sels, procede de preparation, applications, et compositions les renfermant
PL166214B1 (pl) * 1990-06-07 1995-04-28 Wellcome Found Sposób wytwarzania nowych pochodnych indolu PL PL PL PL PL PL PL
ES2104733T3 (es) * 1990-10-15 1997-10-16 Pfizer Derivados de indol.
US5208248A (en) * 1991-01-11 1993-05-04 Merck Sharpe & Dohme, Ltd. Indazole-substituted five-membered heteroaromatic compounds
CZ283018B6 (cs) * 1991-02-01 1997-12-17 Merck Sharp And Dohme Limited Deriváty imidazolu, triazolu a tetrazolu a farmaceutické přípravky na jejich bázi
UA41297C2 (uk) * 1991-11-25 2001-09-17 Пфайзер, Інк. Похідні індолу, фармацевтична композиція і спосіб лікування

Also Published As

Publication number Publication date
DE69307875T2 (de) 1997-05-22
DE69307875D1 (de) 1997-03-13
ES2097496T3 (es) 1997-04-01
KR950700903A (ko) 1995-02-20
PL172232B1 (pl) 1997-08-29
MY115278A (en) 2003-05-31
RU2110516C1 (ru) 1998-05-10
NO309860B1 (no) 2001-04-09
US5498626A (en) 1996-03-12
RU94045902A (ru) 1996-08-27
FI931613A (fi) 1993-10-11
JPH07501831A (ja) 1995-02-23
FI931613A0 (fi) 1993-04-08
JP2544704B2 (ja) 1996-10-16
SK120794A3 (en) 1995-05-10
ZA932536B (en) 1994-10-08
AU3782193A (en) 1993-11-18
EP0635015A1 (en) 1995-01-25
CZ282653B6 (cs) 1997-08-13
FI111256B (fi) 2003-06-30
YU25593A (sh) 1996-10-09
CZ247794A3 (en) 1995-07-12
CA2132706C (en) 1998-08-04
HU9301048D0 (en) 1993-06-28
NO943803D0 (no) 1994-10-07
HUT64060A (en) 1993-11-29
CA2132706A1 (en) 1993-10-28
IL105309A0 (en) 1993-08-18
CN1038506C (zh) 1998-05-27
WO1993021180A1 (en) 1993-10-28
MX9301996A (es) 1994-03-31
EP0635015B1 (en) 1997-01-29
HRP930753B1 (en) 2000-10-31
UA34452C2 (uk) 2001-03-15
NZ251047A (en) 1996-09-25
NO943803L (no) 1994-10-07
KR0179074B1 (ko) 1999-03-20
FI20010214A (fi) 2001-02-05
BR9306221A (pt) 1998-06-30
AU670270B2 (en) 1996-07-11
CN1080288A (zh) 1994-01-05
YU48916B (sh) 2002-11-15
EG20466A (en) 1999-05-31
GR3022767T3 (en) 1997-06-30
TW394769B (en) 2000-06-21
SK278182B6 (en) 1996-03-06
HRP930753A2 (en) 1994-10-31
ATE148465T1 (de) 1997-02-15

Similar Documents

Publication Publication Date Title
DK0635015T3 (da) Acylaminoindolderivater som 5-Htl agonister
NO941918L (no) Indolderivater
MY108909A (en) Indole derivatives
MY111683A (en) Indole derivatives.
KR960704843A (ko) 5-아릴인돌 유도체 (5-arylindole derivatives)
CA2117643A1 (en) Indole Derivatives